Company
Aclaris Therapeutics, Inc. (ACRS)
Standardized SEC financial data for Aclaris Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001557746 · NASDAQ · Pharmaceutical Preparations.
Gross margin
73.3%
Operating margin
-975.9%
Net margin
-829.6%
Revenue growth (YoY)
-58.2%
Return on equity
-63.0%
Free cash flow
-$47.2M
Debt / equity
0.10×
Current ratio
3.36×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $6.5M | $6.8M | $29.8M | $31.2M | $18.7M | $7.8M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.1M | $225.7M | $229.8M | $181.9M | $203.9M | $151.4M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$38.6M | -$52.1M | -$67.6M | -$78.3M | -$20.1M | -$47.1M |
| Capital expenditures |
Get ACRS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ACRS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ACRS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"